West Pharmaceutical Services, Inc. Earnings Dividend

West Pharmaceutical Services, Inc.’s revenue jumped 13.85% since last year same period to $872.3Mn in the Q2 2026. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 3.24% jump in its revenue since last 3-months.

West Pharmaceutical Services, Inc.’s net profit jumped 16.84% since last year same period to $154Mn in the Q2 2026. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 10.95% jump in its net profits since last 3-months.

West Pharmaceutical Services, Inc.’s net profit margin jumped 2.63% since last year same period to 17.65% in the Q2 2026. On a quarterly growth basis, West Pharmaceutical Services, Inc. has generated 7.47% jump in its net profit margins since last 3-months.

West Pharmaceutical Services, Inc.’s earning per share (EPS) estimates for the current quarter stand at 2.18 - a 4.81% jump from last quarter’s estimates.

West Pharmaceutical Services, Inc.’s earning per share (EPS) estimates for the current year stand at 2.18.

West Pharmaceutical Services, Inc.’s earning per share (EPS) jumped 28.8% since last year same period to 2.37 in the Q2 2026. This indicates that the West Pharmaceutical Services, Inc. has generated 28.8% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

West Pharmaceutical Services, Inc. declared 0.22 dividend per share during the earnings announcement for Q2 2026.